Scientists have shown ageing process can be safely and effectively reversed in mice
New research by the Salk Institute has shown cellular rejuvenation therapy safely reverses signs of ageing in mice.
List view / Grid view
New research by the Salk Institute has shown cellular rejuvenation therapy safely reverses signs of ageing in mice.
A scientist at the University of Houston receives a $2 million grant to innovate computer-aided drug discovery for breast cancer.
Researchers from the Technical University of Munich have successfully used specific enzymes to destroy the genetic information of SARS-CoV-2 directly after the virus enters a cell.
Researchers have developed a new way to generate breast tumour models faster, more reliably and with less immune variability than existing models.
Researchers at the University of Texas have redesigned a key component of a CRISPR-based gene-editing tool.
A recent paper highlights how tiny robots with living parts can be designed to effectively deliver drugs to body tissues.
Scientists have gained deeper knowledge about the mislocalisation of a protein, providing a possible therapeutic target that could have implications in treating dementia.
Researchers have developed a new imaging approach that can capture blood vessel images at different spatial scales.
New research from the Karolinska Institutet shows that RNA molecules have a much broader function in the development of cancer.
A new study has revealed a cannabidiol analogue can possibly prevent neuropathic pain induced by chemotherapy, as well as being beneficial against cancer.
A new study modelled chlamydia and HPV co-infection in patient-derived ectocervix organoids to reveal distinct cellular reprogramming.
Scientists have demonstrated how automated, high-throughput life science experiments can be replicated on a modest budget.
A study has shown how Parkinson’s disease may be driven by cell stress-related biochemical events that disrupt a key cellular clean-up system.
Researchers at the US National Heart, Lung, and Blood Institute have discovered new insights about lymphangioleiomyomatosis, a rare lung disease that affects about one in 200,000 Americans.
An iPSC technology leader taps industry veteran to drive growth in cell therapy and drug discovery markets.